Polymers containing enzymatically degradable bonds, XII. Effect of spacer structure on the rate of release of daunomycin and adriamycin from poly [N-(2-hydroxypropyl)-methacrylamide] copolymer drag carriers in vitro and antitumour activity measured in vivo
暂无分享,去创建一个
K. Ulbrich | V. Šubr | R. Duncan | J. Strohalm | I. Hume
[1] K. Ulbrich,et al. Macromolecular prodrugs for use in targeted cancer chemotherapy: melphalan covalently coupled to N- (2-hydroxypropyl) methacrylamide copolymers , 1991 .
[2] K. Ulbrich,et al. N-(2-hydroxypropyl)methacrylamide copolymers targeted to the hepatocyte galactose-receptor: pharmacokinetics in DBA2 mice. , 1991, British Journal of Cancer.
[3] D. Sgouras,et al. Methods for the evaluation of biocompatibility of soluble synthetic polymers which have potential for biomedical use: 1 — Use of the tetrazolium-based colorimetric assay (MTT) as a preliminary screen for evaluation ofin vitro cytotoxicity , 1990 .
[4] K. Ulbrich,et al. The pharmacokinetics of polymer-bound adriamycin. , 1990, Biochemical pharmacology.
[5] K. Ulbrich,et al. Action of polymeric prodrugs based on N-(2-hydroxypropyl)-methacrylamide copolymers. II. Body distribution and T-cell accumulation of free and polymer-bound [125i]daunomycin , 1989 .
[6] K. Ulbrich,et al. Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. 3. Evaluation of adriamycin conjugates against mouse leukaemia L1210 in vivo , 1989 .
[7] K. Ulbrich,et al. Biocompatibility of N-(2-hydroxypropyl) methacrylamide copolymers containing adriamycin. Immunogenicity, and effect on haematopoietic stem cells in bone marrow in vivo and mouse splenocytes and human peripheral blood lymphocytes in vitro. , 1989, Biomaterials.
[8] J. Kopeček,et al. Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. II. Evaluation of daunomycin conjugates in vivo against L1210 leukaemia. , 1988, British Journal of Cancer.
[9] K. Ulbrich,et al. Polymer-bound derivatives of sarcolysin and their antitumour activity against mouse and human leukaemia in vitro , 1987 .
[10] V. Šubr,et al. Degradation of Oligopeptide Sequences Connecting Poly[N-(2- hydroxypropyl)methacrylamide] Chains by Lysosomal Cysteine Proteinases , 1986 .
[11] J. Kopeček,et al. Stability in rat plasma and serum of lysosomally degradable oligopeptide sequences in N-(2-hydroxypropyl) methacrylamide copolymers. , 1985, Biomaterials.
[12] Jindřich Kopeček,et al. Polymers containing enzymatically degradable bonds, 8. Degradation of oligopeptide sequences in N‐(2‐hydroxypropyl)methacrylamide copolymers by bovine spleen cathepsin B , 1983 .
[13] J. Kopeček,et al. Targeting of N-(2-hydroxypropyl)methacrylamide copolymers to liver by incorporation of galactose residues. , 1983, Biochimica et biophysica acta.
[14] J. Kopeček,et al. Degradation of side-chains ofN-(2-hydroxypropyl)methacrylamide copolymers by lysosomal thiol-proteinases , 1982, Bioscience reports.
[15] J. Kopeček,et al. Polymers containing enzymatically degradable bonds, 1. Chymotrypsin catalyzed hydrolysis of p‐nitroanilides of phenylalanine and tyrosine attached to side‐chains of copolymers of N‐(2‐hydroxypropyl)methacrylamide , 1981 .
[16] T. Boat,et al. An improved method for the determination of galactosaminitol, glucosaminitol, glucosamine, and galactosamine on an amino acid analyzer. , 1978, Analytical biochemistry.
[17] G. Fasman,et al. Synthesis and conformational studies of model histones. Sequential and random polypeptides with the composition L-lysyl-L-alanyl-glycine. , 1974, Biochemistry.
[18] K. Brocklehurst,et al. A novel reactivity of papain and a convenient active site titration in the presence of other thiols , 1970, FEBS letters.
[19] A. Berger,et al. On the active site of proteases. 3. Mapping the active site of papain; specific peptide inhibitors of papain. , 1968, Biochemical and biophysical research communications.